Skip to main content
icon for Will Humana (HUM) beat quarterly earnings?
Pendapatan·Sembunyikan Dari Baru

Will Humana (HUM) beat quarterly earnings?

icon for Will Humana (HUM) beat quarterly earnings?
Pendapatan·Sembunyikan Dari Baru

Will Humana (HUM) beat quarterly earnings?

Jul 29

Jul 29

88% peluang
Polymarket
BARU
88% peluang
Polymarket
BARU
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Trader sentiment for Humana beating Q2 2026 earnings sits at an even 50% implied probability ahead of the July 29 release, reflecting balanced views on Medicare Advantage medical loss ratios and potential star-rating recovery. Q1 results showed a solid beat at $10.31 versus $9.97 expected, yet analysts maintain a consensus Hold rating with price targets clustered near $311–$321, citing ongoing pressures in the managed-care sector. Recent upgrades from Deutsche Bank and Mizuho highlight stabilizing enrollment and bonus-payment upside, but consensus 2026 EPS estimates near $9.02 underscore caution on margin expansion. The closely contested market hinges on whether July trends in utilization and plan positioning confirm these improvements or reveal further headwinds.

As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.

If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.)

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Volume
$337
Tanggal Berakhir
Jul 29, 2026
Pasar Dibuka
Jul 15, 2026, 8:49 PM ET

Sumber Resolusi

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Trader sentiment for Humana beating Q2 2026 earnings sits at an even 50% implied probability ahead of the July 29 release, reflecting balanced views on Medicare Advantage medical loss ratios and potential star-rating recovery. Q1 results showed a solid beat at $10.31 versus $9.97 expected, yet analysts maintain a consensus Hold rating with price targets clustered near $311–$321, citing ongoing pressures in the managed-care sector. Recent upgrades from Deutsche Bank and Mizuho highlight stabilizing enrollment and bonus-payment upside, but consensus 2026 EPS estimates near $9.02 underscore caution on margin expansion. The closely contested market hinges on whether July trends in utilization and plan positioning confirm these improvements or reveal further headwinds.

As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.

If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.)

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Volume
$337
Tanggal Berakhir
Jul 29, 2026
Pasar Dibuka
Jul 15, 2026, 8:49 PM ET

Sumber Resolusi

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Terkait

icon for Will Labcorp (LH) beat quarterly earnings?

Will Labcorp (LH) beat quarterly earnings?

91%
icon for Will Waystar (WAY) beat quarterly earnings?

Will Waystar (WAY) beat quarterly earnings?

89%
icon for Will CBOE (CBOE) beat quarterly earnings?

Will CBOE (CBOE) beat quarterly earnings?

81%

Hati-hati dengan link eksternal.

Pertanyaan yang Sering Diajukan

"Will Humana (HUM) beat quarterly earnings?" adalah pasar prediksi di Polymarket di mana trader membeli dan menjual saham "Ya" atau "Tidak" berdasarkan apakah mereka yakin event ini akan terjadi. Probabilitas crowd-sourced saat ini adalah 88% untuk "Yes." Misalnya, jika "Ya" dihargai 88¢, pasar secara kolektif memberikan peluang 88% bahwa event ini akan terjadi. Peluang ini bergeser terus-menerus saat trader bereaksi terhadap perkembangan dan informasi baru. Saham dengan hasil yang benar bisa ditukarkan seharga $1 setiap saham saat pasar diselesaikan.

"Will Humana (HUM) beat quarterly earnings?" adalah pasar yang baru dibuat di Polymarket, diluncurkan pada Jul 15, 2026. Sebagai pasar awal, ini adalah kesempatanmu untuk menjadi salah satu trader pertama yang menetapkan peluang dan membangun sinyal harga awal pasar. Kamu juga bisa menandai halaman ini untuk melacak volume dan aktivitas trading seiring pasar mendapatkan traksi.

Untuk trading di "Will Humana (HUM) beat quarterly earnings?," cukup pilih apakah kamu yakin jawabannya "Ya" atau "Tidak." Setiap sisi memiliki harga saat ini yang mencerminkan probabilitas tersirat pasar. Masukkan jumlah kamu dan klik "Trade." Jika kamu membeli saham "Ya" dan hasilnya diselesaikan sebagai "Ya," setiap saham membayar $1. Jika diselesaikan sebagai "Tidak," saham "Ya" kamu bernilai $0. Kamu juga bisa menjual sahammu kapan saja sebelum resolusi jika kamu ingin mengamankan keuntungan atau memotong kerugian.

Probabilitas saat ini untuk "Will Humana (HUM) beat quarterly earnings?" adalah 88% untuk "Yes." Ini berarti keramaian Polymarket saat ini percaya ada peluang 88% bahwa event ini akan terjadi. Peluang ini diperbarui secara real-time berdasarkan trade aktual, memberikan sinyal yang terus diperbarui tentang apa yang diharapkan pasar.

Aturan resolusi untuk "Will Humana (HUM) beat quarterly earnings?" mendefinisikan dengan tepat apa yang harus terjadi agar setiap hasil dinyatakan sebagai pemenang — termasuk sumber data resmi yang digunakan untuk menentukan hasilnya. Kamu bisa meninjau kriteria resolusi lengkap di bagian "Aturan" di halaman ini di atas komentar. Kami menyarankan membaca aturan dengan cermat sebelum trading, karena mereka menentukan kondisi tepat, kasus khusus, dan sumber yang mengatur bagaimana pasar ini diselesaikan.